Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Because of the problem with Cilotax stent permission
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will compare the stent coverage at 3 months by optical coherence tomography (OCT) between the Cilotax and DESyne drug-eluting stents (DES). The extent of the strut uncoverage has not been evaluated yet for both the Cilotax and DESyne and we first sought to decide the reference intervals using 40 samples (total 44 patients for each group considering 10% drop-out rate) as the pilot study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 CILOTAX arm | Experimental | Cilotax drug-eluting stents implantation |
|
| 2 DESyne arm | Active Comparator | DESyne drug-eluting stents implantation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cilotax drug-eluting stents implantation | Device |
| ||
| DESyne drug-eluting stents implantation |
| Measure | Description | Time Frame |
|---|---|---|
| Stent coverage | The percentage of stent uncoverage measured by OCT | up to 3 months after stent implantation |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
|